ISAKSON JOHN P 4
4 · KV PHARMACEUTICAL CO /DE/ · Filed Sep 24, 2004
Insider Transaction Report
Form 4
KV PHARMACEUTICAL CO /DE/KVA, KVB
ISAKSON JOHN P
Director
Transactions
- Exercise/Conversion
Stock option (right to buy)
2004-09-23−2,500→ 2,500 totalExercise: $10.21Exp: 2007-10-21→ Class B Common Stock (2,500 underlying)
Footnotes (2)
- [F1]20% immediately exercisable; additional 20% exercisable on each succeeding anniversary date of grant, pursuant to K-V Pharmaceutical Company 2001 Incentive Stock Option Plan.
- [F2]This option was previously reported as covering 5,000 shares at an exercise price of $15.31 per share but was adjusted to reflect a 3-for-2 stock split on September 8, 2003.